168 related articles for article (PubMed ID: 10807693)
21. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.
Mitchell TJ; Turajlic S; Rowan A; Nicol D; Farmery JHR; O'Brien T; Martincorena I; Tarpey P; Angelopoulos N; Yates LR; Butler AP; Raine K; Stewart GD; Challacombe B; Fernando A; Lopez JI; Hazell S; Chandra A; Chowdhury S; Rudman S; Soultati A; Stamp G; Fotiadis N; Pickering L; Au L; Spain L; Lynch J; Stares M; Teague J; Maura F; Wedge DC; Horswell S; Chambers T; Litchfield K; Xu H; Stewart A; Elaidi R; Oudard S; McGranahan N; Csabai I; Gore M; Futreal PA; Larkin J; Lynch AG; Szallasi Z; Swanton C; Campbell PJ;
Cell; 2018 Apr; 173(3):611-623.e17. PubMed ID: 29656891
[TBL] [Abstract][Full Text] [Related]
22. Lack of a functional VHL gene product sensitizes renal cell carcinoma cells to the apoptotic effects of the protein synthesis inhibitor verrucarin A.
Woldemichael GM; Turbyville TJ; Vasselli JR; Linehan WM; McMahon JB
Neoplasia; 2012 Aug; 14(8):771-7. PubMed ID: 22952429
[TBL] [Abstract][Full Text] [Related]
23. Molecular diagnosis and therapy of kidney cancer.
Linehan WM; Bratslavsky G; Pinto PA; Schmidt LS; Neckers L; Bottaro DP; Srinivasan R
Annu Rev Med; 2010; 61():329-43. PubMed ID: 20059341
[TBL] [Abstract][Full Text] [Related]
24. Genetic predisposition to kidney cancer.
Schmidt LS; Linehan WM
Semin Oncol; 2016 Oct; 43(5):566-574. PubMed ID: 27899189
[TBL] [Abstract][Full Text] [Related]
25. The genetic basis of kidney cancer: a metabolic disease.
Linehan WM; Srinivasan R; Schmidt LS
Nat Rev Urol; 2010 May; 7(5):277-85. PubMed ID: 20448661
[TBL] [Abstract][Full Text] [Related]
26. VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas.
Lee H; Zhuang L; Gan B
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618953
[TBL] [Abstract][Full Text] [Related]
27. Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population.
Suh J; Jeong CW; Choi S; Ku JH; Kim HH; Kim K; Kwak C
BMC Urol; 2020 Aug; 20(1):125. PubMed ID: 32811483
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological and molecular features of renal cell carcinomas with haemangioblastoma-like features distinct from clear cell renal cell carcinoma.
Kojima F; Matsuzaki I; Musangile FY; Kinoshita Y; Otani T; Abe K; Asai A; Kohjimoto Y; Kondo T; Hara I; Murata SI
Histopathology; 2024 Feb; 84(3):539-549. PubMed ID: 37988260
[TBL] [Abstract][Full Text] [Related]
29. Chromosome 3p Loss-Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma.
Hsieh JJ; Le VH; Oyama T; Ricketts CJ; Ho TH; Cheng EH
J Clin Oncol; 2018 Oct; 36(36):JCO2018792549. PubMed ID: 30372397
[TBL] [Abstract][Full Text] [Related]
30. VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line.
Pilz JF; Klein M; Neumann-Haefelin E; Ganner A
J Kidney Cancer VHL; 2024; 11(1):12-18. PubMed ID: 38304003
[TBL] [Abstract][Full Text] [Related]
31. Kidney scoring surveillance: predictive machine learning models for clear cell renal cell carcinoma growth using MRI.
Yazdian Anari P; Zahergivar A; Gopal N; Chaurasia A; Lay N; Ball MW; Turkbey B; Turkbey E; Jones EC; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2024 Apr; 49(4):1202-1209. PubMed ID: 38347265
[TBL] [Abstract][Full Text] [Related]
32. VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in Clear Cell Renal Cell Carcinoma.
Hu J; Smith DJ; Wu L
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762376
[TBL] [Abstract][Full Text] [Related]
33. Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma.
Meng H; Jiang X; Cui J; Yin G; Shi B; Liu Q; Xuan H; Wang Y
Biomed Res Int; 2020; 2020():2495157. PubMed ID: 33062672
[TBL] [Abstract][Full Text] [Related]
34. Hereditary papillary renal cell carcinoma.
Jacoba IM; Lu Z
Semin Diagn Pathol; 2024 Jan; 41(1):28-31. PubMed ID: 38135585
[TBL] [Abstract][Full Text] [Related]
35. Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
Nguyen CB; Knaus C; Li J; Accardo ML; Koeppe E; Vaishampayan UN; Alva AS; Else T
JCO Precis Oncol; 2023 Sep; 7():e2300168. PubMed ID: 38127826
[TBL] [Abstract][Full Text] [Related]
36. Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.
Han SH; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
Eur Urol Open Sci; 2024 Apr; 62():107-122. PubMed ID: 38496821
[TBL] [Abstract][Full Text] [Related]
37. Exploring the anticancer potential of hydrogen sulfide and BAY‑876 on clear cell renal cell carcinoma cells: Uncovering novel mutations in VHL and KDR genes among ccRCC patients.
Hamadamin PS; Maulood KA
Mol Clin Oncol; 2024 Mar; 20(3):21. PubMed ID: 38332991
[TBL] [Abstract][Full Text] [Related]
38. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.
Purdue MP; Dutta D; Machiela MJ; Gorman BR; Winter T; Okuhara D; Cleland S; Ferreiro-Iglesias A; Scheet P; Liu A; Wu C; Antwi SO; Larkin J; Zequi SC; Sun M; Hikino K; Hajiran A; Lawson KA; Cárcano F; Blanchet O; Shuch B; Nepple KG; Margue G; Sundi D; Diver WR; Folgueira MAAK; van Bokhoven A; Neffa F; Brown KM; Hofmann JN; Rhee J; Yeager M; Cole NR; Hicks BD; Manning MR; Hutchinson AA; Rothman N; Huang WY; Linehan WM; Lori A; Ferragu M; Zidane-Marinnes M; Serrano SV; Magnabosco WJ; ; Vilas A; Decia R; Carusso F; Graham LS; Anderson K; Bilen MA; Arciero C; Pellegrin I; Ricard S; ; Scelo G; Banks RE; Vasudev NS; Soomro N; Stewart GD; Adeyoju A; Bromage S; Hrouda D; Gibbons N; Patel P; Sullivan M; Protheroe A; Nugent FI; Fournier MJ; Zhang X; Martin LJ; Komisarenko M; Eisen T; Cunningham SA; Connolly DC; Uzzo RG; Zaridze D; Mukeria A; Holcatova I; Hornakova A; Foretova L; Janout V; Mates D; Jinga V; Rascu S; Mijuskovic M; Savic S; Milosavljevic S; Gaborieau V; Abedi-Ardekani B; McKay J; Johansson M; Phouthavongsy L; Hayman L; Li J; Lungu I; Bezerra SM; Souza AG; Sares CTG; Reis RB; Gallucci FP; Cordeiro MD; Pomerantz M; Lee GM; Freedman ML; Jeong A; Greenberg SE; Sanchez A; Thompson RH; Sharma V; Thiel DD; Ball CT; Abreu D; Lam ET; Nahas WC; Master VA; Patel AV; Bernhard JC; Freedman ND; Bigot P; Reis RM; Colli LM; Finelli A; Manley BJ; Terao C; Choueiri TK; Carraro DM; Houlston R; Eckel-Passow JE; Abbosh PH; Ganna A; Brennan P; Gu J; Chanock SJ
Nat Genet; 2024 May; 56(5):809-818. PubMed ID: 38671320
[TBL] [Abstract][Full Text] [Related]
39. Radiogenomics and Texture Analysis to Detect von Hippel-Lindau (VHL) Mutation in Clear Cell Renal Cell Carcinoma.
Greco F; D'Andrea V; Beomonte Zobel B; Mallio CA
Curr Issues Mol Biol; 2024 Apr; 46(4):3236-3250. PubMed ID: 38666933
[TBL] [Abstract][Full Text] [Related]
40. Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma.
Pezzicoli G; Ciciriello F; Musci V; Salonne F; Ragno A; Rizzo M
Curr Oncol; 2023 Oct; 30(10):9276-9290. PubMed ID: 37887570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
